Ditchcarbon
  • Customers
  1. Organizations
  2. Elanco
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated a month ago

Elanco

Company website

Elanco Animal Health Incorporated, commonly known as Elanco, is a leading global animal health company headquartered in the United States. Founded in 1954, Elanco has established itself as a key player in the animal health industry, focusing on innovative solutions for both livestock and companion animals. With a strong presence in North America, Europe, and Asia, the company offers a diverse range of products and services, including pharmaceuticals, vaccines, and nutritional products. Elanco's commitment to improving animal health and welfare is evident in its unique offerings, which are designed to enhance productivity and sustainability in animal agriculture. The company has achieved notable milestones, including the launch of several groundbreaking products that address critical health challenges in animals. As a trusted partner in the animal health sector, Elanco continues to strengthen its market position through research and development, ensuring a healthier future for animals and the people who care for them.

DitchCarbon Score

How does Elanco's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

62

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Elanco's score of 62 is higher than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.

79%

Let us know if this data was useful to you

Elanco's reported carbon emissions

In 2024, Elanco reported total carbon emissions of approximately 175,807,000 kg CO2e for Scope 1, 302,607,000 kg CO2e for Scope 2 (market-based), and 496,505,000 kg CO2e for Scope 3 emissions. This brings their total Scope 1 and 2 emissions to about 478,414,000 kg CO2e (market-based). In comparison, in 2023, their emissions were approximately 145,021,000 kg CO2e (Scope 1), 285,188,000 kg CO2e (Scope 2 market-based), and 655,353,000 kg CO2e (Scope 3), indicating a significant increase in emissions across all scopes. Elanco has set ambitious climate commitments, aiming for net zero Scope 1 and 2 greenhouse gas emissions for their Hook office by 2030. Additionally, they are committed to helping customers avoid approximately 21 million metric tons of GHG emissions by 2030, using 2020 as the base year. Their U.K. and Ireland affiliate has also pledged to eliminate internal combustion engine vehicles from its fleet by 2030. Elanco's long-term strategy includes a commitment to the Science Based Targets initiative (SBTi), with a net zero target across all scopes by 2050. They are also working towards purchasing renewable electricity equal to 100% of their electricity consumption by 2030, further solidifying their commitment to sustainability and climate action.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20152018201920202021202220232024
Scope 1
274,550,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
418,271,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
-
-
-
-
000,000,000
000,000,000
000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Elanco's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Elanco is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Elanco is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Dechra

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 2 hours ago

Zoetis

US
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Heska Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Boehringer Ingelheim Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Sanofi

FR
•
Pharmaceutical Preparation Manufacturing
Updated about 2 hours ago

C.H. Boehringer Sohn AG & Co. KG

DE
•
Pharmaceutical Preparation Manufacturing
Updated about 2 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
dev
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy